304 related articles for article (PubMed ID: 7598139)
1. Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women.
Denke MA
Am J Med; 1995 Jul; 99(1):29-35. PubMed ID: 7598139
[TBL] [Abstract][Full Text] [Related]
2. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
[TBL] [Abstract][Full Text] [Related]
3. Concurrent use of simvastatin and estrogen--progestin therapy compared with each therapy alone for hypercholesterolemia in postmenopausal women.
Darling GM; Johns JA; McCloud PI; Davis SR
Climacteric; 1999 Sep; 2(3):181-8. PubMed ID: 11910595
[TBL] [Abstract][Full Text] [Related]
4. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
5. Individual responsiveness to a cholesterol-lowering diet in postmenopausal women with moderate hypercholesterolemia.
Denke MA
Arch Intern Med; 1994 Sep; 154(17):1977-82. PubMed ID: 8074602
[TBL] [Abstract][Full Text] [Related]
6. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
Sbarouni E; Kyriakides ZS; Kremastinos DTh
J Am Coll Cardiol; 1998 Nov; 32(5):1244-50. PubMed ID: 9809932
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
Vigna GB; Donegà P; Zanca R; Barban A; Passaro A; Pansini F; Bonaccorsi G; Mollica G; Fellin R
Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
[TBL] [Abstract][Full Text] [Related]
8. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement and simvastatin in the therapy of hypercholesterolemic postmenopausal women.
Averbuch M; Ayalon D; Eckstein N; Dotan I; Shapira I; Levo Y; Pines A
J Med; 1998; 29(5-6):343-50. PubMed ID: 10503169
[TBL] [Abstract][Full Text] [Related]
10. Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia.
Denke MA; Grundy SM
Arch Intern Med; 1994 Feb; 154(3):317-25. PubMed ID: 8297199
[TBL] [Abstract][Full Text] [Related]
11. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
Sendag F; Karadadas N; Ozsener S; Bilgin O
Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
[TBL] [Abstract][Full Text] [Related]
12. Effects of adding C-19 versus C-21 progestin to conjugated estrogen in moderately hypercholesterolemic postmenopausal women.
Wolfe BM; Koval JJ; Nisker JA
Am J Obstet Gynecol; 1998 Apr; 178(4):787-92. PubMed ID: 9579445
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.
Darling GM; Johns JA; McCloud PI; Davis SR
N Engl J Med; 1997 Aug; 337(9):595-601. PubMed ID: 9271481
[TBL] [Abstract][Full Text] [Related]
14. A comparison of continuous combined hormone replacement therapy, HMG-CoA reductase inhibitor and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Ozsener S; Sendag F; Koc T; Terek MC; Oztekin K; Bilgin O
J Obstet Gynaecol Res; 2001 Dec; 27(6):353-8. PubMed ID: 11794823
[TBL] [Abstract][Full Text] [Related]
15. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
[TBL] [Abstract][Full Text] [Related]
16. Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
Pickar JH; Wild RA; Walsh B; Hirvonen E; Lobo RA
Climacteric; 1998 Mar; 1(1):26-32. PubMed ID: 11913407
[TBL] [Abstract][Full Text] [Related]
17. Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.
Binder EF; Williams DB; Schechtman KB; Jeffe DB; Kohrt WM
Ann Intern Med; 2001 May; 134(9 Pt 1):754-60. PubMed ID: 11329233
[TBL] [Abstract][Full Text] [Related]
18. The effects of hormone replacement therapy on plasma lipids in type II diabetes.
Manwaring P; Morfis L; Diamond T; Howes LG
Maturitas; 2000 Mar; 34(3):239-47. PubMed ID: 10717490
[TBL] [Abstract][Full Text] [Related]
19. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
[TBL] [Abstract][Full Text] [Related]
20. Effect of continuous administration of conjugated estrogen plus medroxyprogesterone acetate (Premelle) in postmenopausal women in Taiwan.
Yang TS; Wang HL; Chen YJ; Chang SP; Yuan CC
J Chin Med Assoc; 2004 Jul; 67(7):336-43. PubMed ID: 15510930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
